Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Pathogenicity and selective constraint on variation near splice sites.

Lord J, Gallone G, Short PJ, McRae JF, Ironfield H, Wynn EH, Gerety SS, He L, Kerr B, Johnson DS, McCann E, Kinning E, Flinter F, Temple IK, Clayton-Smith J, McEntagart M, Lynch SA, Joss S, Douzgou S, Dabir T, Clowes V, McConnell VPM, Lam W, Wright CF, FitzPatrick DR, Firth HV, Barrett JC, Hurles ME; Deciphering Developmental Disorders study.

Genome Res. 2019 Feb;29(2):159-170. doi: 10.1101/gr.238444.118. Epub 2018 Dec 26.

2.

Quantifying the contribution of recessive coding variation to developmental disorders.

Martin HC, Jones WD, McIntyre R, Sanchez-Andrade G, Sanderson M, Stephenson JD, Jones CP, Handsaker J, Gallone G, Bruntraeger M, McRae JF, Prigmore E, Short P, Niemi M, Kaplanis J, Radford EJ, Akawi N, Balasubramanian M, Dean J, Horton R, Hulbert A, Johnson DS, Johnson K, Kumar D, Lynch SA, Mehta SG, Morton J, Parker MJ, Splitt M, Turnpenny PD, Vasudevan PC, Wright M, Bassett A, Gerety SS, Wright CF, FitzPatrick DR, Firth HV, Hurles ME, Barrett JC; Deciphering Developmental Disorders Study.

Science. 2018 Dec 7;362(6419):1161-1164. doi: 10.1126/science.aar6731. Epub 2018 Nov 8.

PMID:
30409806
3.

De novo mutations in regulatory elements in neurodevelopmental disorders.

Short PJ, McRae JF, Gallone G, Sifrim A, Won H, Geschwind DH, Wright CF, Firth HV, FitzPatrick DR, Barrett JC, Hurles ME.

Nature. 2018 Mar 29;555(7698):611-616. doi: 10.1038/nature25983. Epub 2018 Mar 21.

4.

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

Jabbal S, Anderson W, Short P, Morrison A, Manoharan A, Lipworth BJ.

QJM. 2017 Jul 24. doi: 10.1093/qjmed/hcx155. [Epub ahead of print]

PMID:
29025008
5.

Thyrotoxicosis and Choledocholithiasis Masquerading as Thyroid Storm.

Horn CL, Short PA.

Case Rep Med. 2017;2017:9454698. doi: 10.1155/2017/9454698. Epub 2017 Aug 23.

6.

Tunable Surface Repellency Maintains Stemness and Redox Capacity of Human Mesenchymal Stem Cells.

Balikov DA, Crowder SW, Boire TC, Lee JB, Gupta MK, Fenix AM, Lewis HN, Ambrose CM, Short PA, Kim CS, Burnette DT, Reilly MA, Murthy NS, Kang ML, Kim WS, Sung HJ.

ACS Appl Mater Interfaces. 2017 Jul 12;9(27):22994-23006. doi: 10.1021/acsami.7b06103. Epub 2017 Jun 29.

7.

Erratum to: Comparative lung bioavailability of fluticasone/salmeterol via a breath-actuated spacer and conventional plastic spacers.

Nair A, McKinlay L, Williamson P, Short P, Burns P, Lipworth BJ.

Eur J Clin Pharmacol. 2017 Jun;73(6):793. doi: 10.1007/s00228-017-2259-6. No abstract available.

PMID:
28447126
8.

Design and use of mouse control DNA for DNA biomarker extraction and PCR detection from urine: Application for transrenal Mycobacterium tuberculosis DNA detection.

Bordelon H, Ricks KM, Pask ME, Russ PK, Solinas F, Baglia ML, Short PA, Nel A, Blackburn J, Dheda K, Zamudio C, Cáceres T, Wright DW, Haselton FR, Pettit AC.

J Microbiol Methods. 2017 May;136:65-70. doi: 10.1016/j.mimet.2017.02.010. Epub 2017 Mar 9.

9.

Inhaled corticosteroid dose response in asthma: Should we measure inflammation?

Anderson WJ, Short PM, Jabbal S, Lipworth BJ.

Ann Allergy Asthma Immunol. 2017 Feb;118(2):179-185. doi: 10.1016/j.anai.2016.11.018. Epub 2017 Jan 3.

PMID:
28065396
10.

Is Gly16Arg β2 Receptor Polymorphism Related to Impulse Oscillometry in a Real-Life Asthma Clinic Setting?

Jabbal S, Manoharan A, Lipworth J, Anderson W, Short P, Lipworth B.

Lung. 2016 Apr;194(2):267-71. doi: 10.1007/s00408-016-9848-5. Epub 2016 Feb 15.

11.

Inhaled corticosteroid dose-response on blood eosinophils in asthma.

Lipworth B, Jabbal S, Manoharan A, Anderson W, Short P.

Lancet Respir Med. 2016 Jan;4(1):e1. doi: 10.1016/S2213-2600(15)00504-4. No abstract available.

PMID:
26762665
12.

From mouse to man: predicting biased effects of beta-blockers in asthma.

Lipworth BJ, Anderson WJ, Short PM.

Br J Pharmacol. 2016 Jan;173(1):248-9. doi: 10.1111/bph.13335. No abstract available.

13.

Effects of Hospital Type and Distance on Lymph Node Assessment for Colon Cancer Among Metropolitan and Nonmetropolitan Patients in Appalachia.

Short PF, Moran JR, Yang TC, Camacho F, Gusani NJ, Mackley HB, Matthews SA, Anderson RT.

Med Care Res Rev. 2016 Oct;73(5):546-64. doi: 10.1177/1077558715619052. Epub 2015 Nov 27.

14.

The Importance of Clinical Context When Interpreting Serum Ammonia Levels: A Teachable Moment.

Howells JW, Short PA.

JAMA Intern Med. 2015 Dec;175(12):1902-3. doi: 10.1001/jamainternmed.2015.5772. Review. No abstract available.

PMID:
26457849
15.

Towards programming immune tolerance through geometric manipulation of phosphatidylserine.

Roberts RA, Eitas TK, Byrne JD, Johnson BM, Short PJ, McKinnon KP, Reisdorf S, Luft JC, DeSimone JM, Ting JP.

Biomaterials. 2015 Dec;72:1-10. doi: 10.1016/j.biomaterials.2015.08.040. Epub 2015 Aug 20.

16.

Automated Device for Asynchronous Extraction of RNA, DNA, or Protein Biomarkers from Surrogate Patient Samples.

Bitting AL, Bordelon H, Baglia ML, Davis KM, Creecy AE, Short PA, Albert LE, Karhade AV, Wright DW, Haselton FR, Adams NM.

J Lab Autom. 2016 Dec;21(6):732-742. Epub 2015 Jul 20.

PMID:
26194105
17.

Regular Formal Evaluation Sessions are Effective as Frame-of-Reference Training for Faculty Evaluators of Clerkship Medical Students.

Hemmer PA, Dadekian GA, Terndrup C, Pangaro LN, Weisbrod AB, Corriere MD, Rodriguez R, Short P, Kelly WF.

J Gen Intern Med. 2015 Sep;30(9):1313-8. doi: 10.1007/s11606-015-3294-6.

18.

Reducing Medicaid Churning: Extending Eligibility For Twelve Months Or To End Of Calendar Year Is Most Effective.

Swartz K, Short PF, Graefe DR, Uberoi N.

Health Aff (Millwood). 2015 Jul;34(7):1180-7. doi: 10.1377/hlthaff.2014.1204.

19.

Usefulness of impulse oscillometry for the assessment of airway hyperresponsiveness in mild-to-moderate adult asthma.

Short PM, Anderson WJ, Manoharan A, Lipworth BJ.

Ann Allergy Asthma Immunol. 2015 Jul;115(1):17-20. doi: 10.1016/j.anai.2015.04.022.

PMID:
26123421
20.

Impact of Left Ventricular Hypertrophy on Survival in Chronic Obstructive Pulmonary Disease.

Short PM, Anderson WJ, Elder DH, Struthers AD, Lipworth BJ.

Lung. 2015 Aug;193(4):487-95. doi: 10.1007/s00408-015-9724-8. Epub 2015 Mar 29.

PMID:
25821177
21.

An End-of-Year Oral Examination for Internal Medicine Residents: An Assessment Tool for the Clinical Competency Committee.

Mount CA, Short PA, Mount GR, Schofield CM.

J Grad Med Educ. 2014 Sep;6(3):551-4. doi: 10.4300/JGME-D-13-00365.1.

22.

Impact of long-acting bronchodilators and exposure to inhaled corticosteroids on mortality in COPD: a real-life retrospective cohort study.

Manoharan A, Short PM, Anderson WJ, Lipworth BJ.

Lung. 2014 Oct;192(5):649-52. doi: 10.1007/s00408-014-9611-8. Epub 2014 Jun 22.

PMID:
24952426
23.

The inverse agonist propranolol confers no corticosteroid-sparing activity in mild-to-moderate persistent asthma.

Anderson WJ, Short PM, Williamson PA, Manoharan A, Lipworth BJ.

Clin Sci (Lond). 2014 Dec;127(11):635-43. doi: 10.1042/CS20140249.

PMID:
24938324
24.

Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?

Harrison MT, Short P, Williamson PA, Singanayagam A, Chalmers JD, Schembri S.

Thorax. 2014 Jul;69(7):609-15. doi: 10.1136/thoraxjnl-2013-203996. Epub 2014 Apr 17.

PMID:
24743560
25.

Does rurality influence treatment decisions in early stage laryngeal cancer?

Mackley HB, Teslova T, Camacho F, Short PF, Anderson RT.

J Rural Health. 2014 Fall;30(4):406-11. doi: 10.1111/jrh.12069. Epub 2014 Mar 21.

PMID:
24654995
26.

Influence of β2-adrenoceptor 16 genotype on propranolol-induced bronchoconstriction in patients with persistent asthma.

Anderson WJ, Short PM, Manoharan A, Lipworth JL, Lipworth BJ.

Ann Allergy Asthma Immunol. 2014 May;112(5):475-6. doi: 10.1016/j.anai.2014.02.016. Epub 2014 Mar 18. No abstract available.

PMID:
24650443
27.

Reply: Pharmacological obfuscation of clinical relevance.

Lipworth B, Short P, Anderson W, Williamson P.

Am J Respir Crit Care Med. 2014 Feb 1;189(3):360-1. doi: 10.1164/rccm.201306-1166LE. No abstract available.

PMID:
24484335
28.

Design criteria for developing low-resource magnetic bead assays using surface tension valves.

Adams NM, Creecy AE, Majors CE, Wariso BA, Short PA, Wright DW, Haselton FR.

Biomicrofluidics. 2013 Jan 18;7(1):14104. doi: 10.1063/1.4788922. eCollection 2013.

29.

Does cancer reduce labor market entry? Evidence for prime-age females.

Moran JR, Short PF.

Med Care Res Rev. 2014 Jun;71(3):224-42. doi: 10.1177/1077558713510359. Epub 2013 Nov 14.

30.

Effects of intravenous and oral β-blockade in persistent asthmatics controlled on inhaled corticosteroids.

Short PM, Anderson WJ, Williamson PA, Lipworth BJ.

Heart. 2014 Feb;100(3):219-23. doi: 10.1136/heartjnl-2013-304769. Epub 2013 Nov 7.

PMID:
24203262
31.

Adverse effects of long-acting beta-agonists on airway hyperresponsiveness.

Lipworth B, Manoharan A, Short P.

Am J Respir Cell Mol Biol. 2013 Sep;49(3):501-2. doi: 10.1165/rcmb.2013-0139LE. No abstract available.

PMID:
23991662
32.

Access to preventive health care for cancer survivors.

Robin Yabroff K, Short PF, Machlin S, Dowling E, Rozjabek H, Li C, McNeel T, Ekwueme DU, Virgo KS.

Am J Prev Med. 2013 Sep;45(3):304-12. doi: 10.1016/j.amepre.2013.04.021.

33.

Proof-of-concept evaluation of trough airway hyper-responsiveness following regular racemic or levosalbutamol in genotype-stratified steroid-treated persistent asthmatic patients.

Anderson WJ, Short PM, Williamson PA, Morrison AE, Palmer C, Tavendale R, Lipworth BJ.

Clin Sci (Lond). 2014 Jan 1;126(1):75-83. doi: 10.1042/CS20130213.

PMID:
23829494
34.

Randomized placebo-controlled trial to evaluate chronic dosing effects of propranolol in asthma.

Short PM, Williamson PA, Anderson WJ, Lipworth BJ.

Am J Respir Crit Care Med. 2013 Jun 15;187(12):1308-14. doi: 10.1164/rccm.201212-2206OC.

PMID:
23593932
35.

Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies.

Schembri S, Williamson PA, Short PM, Singanayagam A, Akram A, Taylor J, Singanayagam A, Hill AT, Chalmers JD.

BMJ. 2013 Mar 20;346:f1235. doi: 10.1136/bmj.f1235.

36.

Explaining differential effects of tiotropium on mortality in COPD.

Lipworth BJ, Short PM.

Thorax. 2013 Jun;68(6):589-90. doi: 10.1136/thoraxjnl-2012-203176. Epub 2013 Jan 31. No abstract available.

PMID:
23370440
37.

Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial.

Anderson WJ, Short PM, Williamson PA, Lipworth BJ.

Chest. 2012 Dec;142(6):1553-1561. doi: 10.1378/chest.12-1310.

PMID:
23364390
38.

Tiotropium in asthma.

Lipworth B, Manoharan A, Short P.

N Engl J Med. 2012 Dec 27;367(26):2552; author reply 2553. doi: 10.1056/NEJMc1213076. No abstract available.

PMID:
23268673
39.

Sensitivity of impulse oscillometry and spirometry in beta-blocker induced bronchoconstriction and beta-agonist bronchodilatation in asthma.

Short PM, Williamson PA, Lipworth BJ.

Ann Allergy Asthma Immunol. 2012 Dec;109(6):412-5. doi: 10.1016/j.anai.2012.09.010. Epub 2012 Oct 18.

PMID:
23176879
40.

TNFα signals through specialized factories where responsive coding and miRNA genes are transcribed.

Papantonis A, Kohro T, Baboo S, Larkin JD, Deng B, Short P, Tsutsumi S, Taylor S, Kanki Y, Kobayashi M, Li G, Poh HM, Ruan X, Aburatani H, Ruan Y, Kodama T, Wada Y, Cook PR.

EMBO J. 2012 Nov 28;31(23):4404-14. doi: 10.1038/emboj.2012.288. Epub 2012 Oct 26.

41.

New estimates of gaps and transitions in health insurance.

Short PF, Graefe DR, Swartz K, Uberoi N.

Med Care Res Rev. 2012 Dec;69(6):721-36. doi: 10.1177/1077558712454195. Epub 2012 Jul 24.

42.

Inhaled and systemic corticosteroid response in severe asthma assessed by alveolar nitric oxide: a randomized crossover pilot study of add-on therapy.

Williamson PA, Short PM, Vaidyanathan S, Lipworth BJ.

Br J Clin Pharmacol. 2013 Jan;75(1):93-102. doi: 10.1111/j.1365-2125.2012.04319.x.

43.

Cases of cutaneous diphtheria in New Zealand: implications for surveillance and management.

Sears A, McLean M, Hingston D, Eddie B, Short P, Jones M.

N Z Med J. 2012 Feb 24;125(1350):64-71.

PMID:
22382258
44.

Effects of extra-fine inhaled and oral corticosteroids on alveolar nitric oxide in COPD.

Short PM, Williamson PA, Lipworth BJ.

Lung. 2012 Aug;190(4):395-401. doi: 10.1007/s00408-012-9378-8. Epub 2012 Feb 22.

PMID:
22350679
45.

Effects of intranasal salmeterol and fluticasone given alone and in combination in persistent allergic rhinitis.

Lipworth BJ, Short P, Burns P, Nair A.

Ann Allergy Asthma Immunol. 2012 Jan;108(1):54-59. doi: 10.1016/j.anai.2011.10.001. Epub 2011 Nov 2.

PMID:
22192967
46.

Working at arthritis.

Short P, Jones AC, Walker D, Kavanaugh A, Moots RJ.

Rheumatology (Oxford). 2012 Feb;51(2):201-3. doi: 10.1093/rheumatology/ker415. Epub 2011 Dec 16. No abstract available.

PMID:
22179726
47.

Effects of hydrocortisone on acute β-adrenoceptor blocker and histamine induced bronchoconstriction.

Short PM, Williamson PA, Lipworth BJ.

Br J Clin Pharmacol. 2012 May;73(5):717-26. doi: 10.1111/j.1365-2125.2011.04143.x.

48.

A randomized primary care trial of steroid titration against mannitol in persistent asthma: STAMINA trial.

Lipworth BJ, Short PM, Williamson PA, Clearie KL, Fardon TC, Jackson CM.

Chest. 2012 Mar;141(3):607-615. doi: 10.1378/chest.11-1748. Epub 2011 Oct 13.

PMID:
21998259
49.

Relationships between airway hyperresponsiveness, inflammation, and calibre in asthma.

Short PM, Lipworth SI, Lipworth BJ.

Lung. 2011 Dec;189(6):493-7. doi: 10.1007/s00408-011-9328-x. Epub 2011 Oct 8.

PMID:
21984113
50.

Single wall carbon nanotubes enter cells by endocytosis and not membrane penetration.

Yaron PN, Holt BD, Short PA, Lösche M, Islam MF, Dahl KN.

J Nanobiotechnology. 2011 Sep 30;9:45. doi: 10.1186/1477-3155-9-45.

Supplemental Content

Support Center